{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T21:20:01Z","timestamp":1795036801415,"version":"4.10.2"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T00:00:00Z","timestamp":1778371200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Open Science"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.euros.2026.05.014","type":"journal-article","created":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T16:20:21Z","timestamp":1781454021000},"page":"1-7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Incorporating Lower Urinary Tract Symptoms to Predict the Risk of Positive Prostate Magnetic Resonance Imaging"],"prefix":"10.1016","volume":"90","author":[{"given":"Leonor Jane","family":"Paulino Pereira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harm H.E.","family":"van Melick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiel J.P.M.","family":"Sedelaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco H.","family":"Blanker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pim J.","family":"van Leeuwen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roderick C.N.","family":"van den Bergh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euros.2026.05.014_b0005","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.euo.2018.02.010","article-title":"Prostate cancer risk assessment in biopsy-na\u00efve patients: the Rotterdam prostate cancer risk calculator in multiparametric magnetic resonance imaging-transrectal ultrasound (TRUS) fusion biopsy and systematic TRUS biopsy","volume":"1","author":"Mannaerts","year":"2018","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.euros.2026.05.014_b0010","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0140-6736(16)32401-1","article-title":"Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study","volume":"389","author":"Ahmed","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.euros.2026.05.014_b0015","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1056\/NEJMoa1801993","article-title":"MRI-Targeted or standard biopsy for prostate-cancer diagnosis","volume":"378","author":"Kasivisvanathan","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.euros.2026.05.014_b0020","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.eururo.2024.03.027","article-title":"EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer-2024 Update. Part I: screening, diagnosis, and local treatment with curative intent","volume":"86","author":"Cornford","year":"2024","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2026.05.014_b0025","doi-asserted-by":"crossref","first-page":"28.e21","DOI":"10.1016\/j.urolonc.2023.11.004","article-title":"Clinical significance of prostate cancer identified by transperineal standard template biopsy in men with nonsuspicious multiparametric magnetic resonance imaging","volume":"42","author":"Dahl","year":"2024","journal-title":"Urol Oncol"},{"key":"10.1016\/j.euros.2026.05.014_b0030","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1001\/jamaoncol.2020.7589","article-title":"Comparison of multiparametric magnetic resonance imaging-targeted biopsy with systematic transrectal ultrasonography biopsy for biopsy-naive men at risk for prostate cancer: a phase 3 randomized clinical trial","volume":"7","author":"Klotz","year":"2021","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.euros.2026.05.014_b0035","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.eururo.2018.11.023","volume":"75","author":"van der Leest","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2026.05.014_b0040","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S1470-2045(18)30569-2","article-title":"Use of prostate systematic and targeted biopsy on the basis of multiparametric MRI in biopsy-naive patients (MRI-FIRST): a prospective, multicentre, paired diagnostic study","volume":"20","author":"Rouvi\u00e8re","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.euros.2026.05.014_b0045","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.eururo.2019.06.023","article-title":"Prostate magnetic resonance imaging, with or without magnetic resonance imaging-targeted biopsy, and systematic biopsy for detecting prostate cancer: a cochrane systematic review and meta-analysis","volume":"77","author":"Drost","year":"2020","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2026.05.014_b0050","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.eururo.2018.06.022","article-title":"Prostate cancer diagnostics using a combination of the Stockholm3 blood test and multiparametric magnetic resonance imaging","volume":"74","author":"Gr\u00f6nberg","year":"2018","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2026.05.014_b0055","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s12916-020-01548-3","article-title":"Clinical utility and cost modelling of the phi test to triage referrals into image-based diagnostic services for suspected prostate cancer: the PRIM (Phi to RefIne Mri) study","volume":"18","author":"Kim","year":"2020","journal-title":"BMC Med"},{"key":"10.1016\/j.euros.2026.05.014_b0060","unstructured":"Ng M, Leslie SW, Baradhi KM. Benign Prostatic Hyperplasia. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026."},{"key":"10.1016\/j.euros.2026.05.014_b0065","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.eururo.2009.08.025","article-title":"A risk-based strategy improves prostate-specific antigen-driven detection of prostate cancer","volume":"57","author":"Roobol","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2026.05.014_b0070","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.eururo.2015.08.038","article-title":"Synopsis of the PI-RADS v2 guidelines for multiparametric prostate magnetic resonance imaging and recommendations for use","volume":"69","author":"Barentsz","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2026.05.014_b0075","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/PAS.0000000000000820","article-title":"Contemporary Gleason Grading of Prostatic Carcinoma: An Update With Discussion on Practical Issues to Implement the 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma","volume":"41","author":"Epstein","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.euros.2026.05.014_b0080","doi-asserted-by":"crossref","first-page":"W1","DOI":"10.7326\/M14-0698","article-title":"Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): explanation and elaboration","volume":"162","author":"Moons","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.euros.2026.05.014_b0085","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/j.1365-2362.2011.02562.x","article-title":"Assessing the incremental value of diagnostic and prognostic markers: a review and illustration","volume":"42","author":"Steyerberg","year":"2012","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.euros.2026.05.014_b0090","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s41512-019-0064-7","article-title":"A simple, step-by-step guide to interpreting decision curve analysis","volume":"3","author":"Vickers","year":"2019","journal-title":"Diagn Progn Res"},{"key":"10.1016\/j.euros.2026.05.014_b0095","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.eururo.2023.04.008","article-title":"Summary Paper on the 2023 European Association of Urology Guidelines on the management of non-neurogenic male lower urinary tract symptoms","volume":"84","author":"Gravas","year":"2023","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2026.05.014_b0100","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S1470-2045(22)00016-X","article-title":"Multiparametric ultrasound versus multiparametric MRI to diagnose prostate cancer (CADMUS): a prospective, multicentre, paired-cohort, confirmatory study","volume":"23","author":"Grey","year":"2022","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.euros.2026.05.014_b0105","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1002\/ijc.23713","article-title":"Lower urinary tract symptoms and risk of prostate cancer: the HUNT 2 Cohort","volume":"123","author":"Martin","year":"2008","journal-title":"Norway. Int J cancer"},{"key":"10.1016\/j.euros.2026.05.014_b0110","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1111\/j.1464-410X.2012.10962.x","article-title":"The absence of voiding symptoms in men with a prostate-specific antigen (PSA) concentration of \u22653.0 ng\/mL is an independent risk factor for prostate cancer: results from the Gothenburg Randomized Screening Trial","volume":"110","author":"Fr\u00e5nlund","year":"2012","journal-title":"BJU Int"},{"key":"10.1016\/j.euros.2026.05.014_b0115","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/S0022-5347(17)36966-5","article-title":"The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association","volume":"148","author":"Barry","year":"1992","journal-title":"J Urol"},{"key":"10.1016\/j.euros.2026.05.014_b0120","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.eururo.2011.11.012","article-title":"Prediction of prostate cancer risk: the role of prostate volume and digital rectal examination in the ERSPC risk calculators","volume":"61","author":"Roobol","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2026.05.014_b0125","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s00345-011-0804-y","article-title":"Importance of prostate volume in the European Randomised Study of Screening for Prostate Cancer (ERSPC) risk calculators: results from the prostate biopsy collaborative group","volume":"30","author":"Roobol","year":"2012","journal-title":"World J Urol"},{"key":"10.1016\/j.euros.2026.05.014_b0130","doi-asserted-by":"crossref","first-page":"5100","DOI":"10.3390\/cancers14205100","article-title":"A clinically significant prostate cancer predictive model using digital rectal examination prostate volume category to stratify initial prostate cancer suspicion and reduce magnetic resonance imaging demand","volume":"14","author":"Morote","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.euros.2026.05.014_b0135","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1370\/afm.2205","article-title":"Digital rectal examination for prostate cancer screening in primary care: a systematic review and meta-analysis","volume":"16","author":"Naji","year":"2018","journal-title":"Ann Fam Med"},{"key":"10.1016\/j.euros.2026.05.014_b0140","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1001\/jamaoncol.2020.7456","article-title":"Population-based prostate cancer screening with magnetic resonance imaging or ultrasonography: the IP1-PROSTAGRAM study","volume":"7","author":"Eldred-Evans","year":"2021","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.euros.2026.05.014_b0145","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1056\/NEJMoa2209454","article-title":"Prostate cancer screening with PSA and MRI followed by targeted biopsy only","volume":"387","author":"Hugosson","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.euros.2026.05.014_b0150","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.eururo.2022.03.003","article-title":"A prospective multicenter comparison study of risk-adapted ultrasound-directed and magnetic resonance imaging-directed diagnostic pathways for suspected prostate cancer in biopsy-na\u00efve men","volume":"82","author":"Wagensveld","year":"2022","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2026.05.014_b0155","article-title":"Prostate MRI, with or without MRI-targeted biopsy, and systematic biopsy for detecting prostate cancer","volume":"4","author":"Drost","year":"2019","journal-title":"Cochrane database Syst Rev"},{"key":"10.1016\/j.euros.2026.05.014_b0160","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1148\/radiol.2020190646","article-title":"Variability of the positive predictive value of PI-RADS for prostate MRI across 26 centers: experience of the society of abdominal radiology prostate cancer disease-focused panel","volume":"296","author":"Westphalen","year":"2020","journal-title":"Radiology"},{"key":"10.1016\/j.euros.2026.05.014_b0165","doi-asserted-by":"crossref","first-page":"3383","DOI":"10.1007\/s00330-019-06654-2","article-title":"Interreader variability in prostate MRI reporting using prostate imaging reporting and data system version 2.1","volume":"30","author":"Brembilla","year":"2020","journal-title":"Eur Radiol"},{"key":"10.1016\/j.euros.2026.05.014_b0170","doi-asserted-by":"crossref","first-page":"357","DOI":"10.2214\/AJR.18.20103","article-title":"Abbreviated biparametric versus standard multiparametric MRI for diagnosis of prostate cancer: a systematic review and meta-analysis","volume":"212","author":"Kang","year":"2019","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.euros.2026.05.014_b0175","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1148\/radiol.2017170129","article-title":"Abbreviated biparametric prostate MR imaging in men with elevated prostate-specific antigen","volume":"285","author":"Kuhl","year":"2017","journal-title":"Radiology"},{"key":"10.1016\/j.euros.2026.05.014_b0180","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2214\/AJR.20.24268","article-title":"PI-RADS Committee Position on MRI without contrast medium in biopsy-naive men with suspected prostate cancer: narrative review","volume":"216","author":"Schoots","year":"2021","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.euros.2026.05.014_b0185","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1016\/j.ejrad.2016.10.009","article-title":"Biparametric 3T Magnetic Resonance Imaging for prostatic cancer detection in a biopsy-na\u00efve patient population: a further improvement of PI-RADS v2?","volume":"85","author":"Stanzione","year":"2016","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.euros.2026.05.014_b0190","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1007\/s00261-019-01934-3","article-title":"Prostate cancer detection with biparametric magnetic resonance imaging (bpMRI) by readers with different experience: performance and comparison with multiparametric (mpMRI)","volume":"44","author":"Gatti","year":"2019","journal-title":"Abdom Radiol (NY)"},{"key":"10.1016\/j.euros.2026.05.014_b0195","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1590\/s1677-5538.ibju.2018.0496","article-title":"Prospective comparison of the novel visual prostate symptom score (VPSS) versus the international prostate symptom score (IPSS), and assessment of patient pain perception with regard to transrectal ultrasound guided prostate biopsy","volume":"45","author":"Els","year":"2019","journal-title":"Int Braz J Urol"}],"container-title":["European Urology Open Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666168326005148?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666168326005148?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T21:00:08Z","timestamp":1795035608000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666168326005148"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":39,"alternative-id":["S2666168326005148"],"URL":"https:\/\/doi.org\/10.1016\/j.euros.2026.05.014","relation":{},"ISSN":["2666-1683"],"issn-type":[{"value":"2666-1683","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incorporating Lower Urinary Tract Symptoms to Predict the Risk of Positive Prostate Magnetic Resonance Imaging","name":"articletitle","label":"Article Title"},{"value":"European Urology Open Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euros.2026.05.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of European Association of Urology.","name":"copyright","label":"Copyright"}]}}